Get to know our clinical trials

Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, need for transfusion

THE AIM OF OUR TRIAL IS TO EVALUATE WHETHER THE ADMINISTRATION OF OCTREOTIDE IN LAPAROSCOPIC LIVER RESECTION SURGERY IS EFFECTIVE IN REDUCING INTRAOPERATIVE BLEEDING, THE NEED FOR DRUGS TO MAINTAIN BLOOD PRESSURE DURING SURGERY, AND TO IMPROVE RECOVERY AFTER SURGERY.

Status
In recruitment
headquarters
Pamplona
Early phase

Technical Summary

  • EFFICACY AND SAFETY OF OCTREOTIDE IN LAPAROSCOPIC HEPATECTOMY SURGERY: EFFECT ON BLOOD LOSS, NEED FOR VASOACTIVE DRUGS, NEED FOR TRANSFUSION
  • Code EudraCT: 2023-503613-29-00
  • Protocol number: HEPA-OCT
  • Promoter: Clinica Universidad de Navarra

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.